Skip to content
Operating

Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss

Analysis

StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2022
Last reportedQ1 2026May 6, 2026

How to read this metric

A gain indicates the initial investment has appreciated in value, while a loss suggests a decline in the value of the initial stake.

Detailed definition

This represents the gain or loss recognized when a company increases its ownership in an entity from a minority stake to...

Peer comparison

Occurs sporadically for companies that grow through staged acquisitions.

Metric ID: operating_business_combination_step_acquisition_equity_i_828913

Historical Data

9 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q4 '23Q4 '24Q1 '25Q4 '25Q1 '26
Value$0$0$0$0$0$30.4M$0$0$65.2M
QoQ Change-100.0%
YoY Change-100.0%
Range$0$65.2M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Edwards Lifesciences's business combination step acquisition equity interest in acquiree remeasurement gain or loss?
Edwards Lifesciences (EW) reported business combination step acquisition equity interest in acquiree remeasurement gain or loss of $65.2M in Q1 2026.
What does business combination step acquisition equity interest in acquiree remeasurement gain or loss mean?
The accounting gain or loss from revaluing an existing investment during a buyout.